Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Bio-Techne (TECH) Long-Term Deferred Tax (2025)

Bio-Techne (TECH) has 3 years of Long-Term Deferred Tax data on record, last reported at $10.3 million in Q2 2025.

For Q2 2025, Long-Term Deferred Tax changed N/A year-over-year to $10.3 million; the TTM value through Jun 2025 reached $10.3 million, changed N/A, while the annual FY2025 figure was $10.3 million, N/A changed from the prior year.
Long-Term Deferred Tax reached $10.3 million in Q2 2025 per TECH's latest filing, up from $539000.0 in the prior quarter.
Across five years, Long-Term Deferred Tax topped out at $10.3 million in Q2 2025 and bottomed at $10.3 million in Q2 2025.